FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362578660> ?p ?o ?g. }

• W4362578660 endingPage "S62" @default.
• W4362578660 startingPage "S62" @default.
• W4362578660 abstract "Microbiota-derived short chain fatty acids, particularly butyrate (BA), show multiple beneficial influences on health. In the colon, BA ranges from 10-20 mM and up to 99% is utilized as a metabolic fuel by the mucosa. BA plays a key role in epithelial barrier regulation, reduces inflammation, and regulates cell growth and differentiation. There are multiple mechanisms by which BA contributes to gut health, many due to its regulatory capacity for gene expression. Our group reported (PMID: 34190032) a direct influence of BA on the stabilization of the transcription factor hypoxia-inducible factor (HIF). It is known that HIF stabilization is essential for appropriate mucosal barrier regulation and the coordination of regenerative capacity in the intestine. However, BA is constantly metabolized limiting its HIF stabilization effect. This observation led to the design and investigation of BA-mimicking compounds that stabilize HIF, but may not be involved in metabolism. We hypothesize that structural modifications of BA yield analogues that stabilize HIF with better efficacy and a longer biological half-life. A library of BA derivatives was screened in search of a non-endogenous analogue with higher potency and/or longer half-life for HIF stabilization. In vitro screenings at physiologically-relevant concentrations (5 mM) were performed using intestinal epithelial cell lines (T84 and CaCO2) in normoxia to determine HIF-1a protein abundance. Various analogues stabilized HIF, with 4-mercapto-butyrate (MBA) being the most promising candidate. The best analogues were validated through the induction of classic HIF gene targets, including BNIP3 and CAIX by q-PCR. MBA exhibited higher induction of these targets compared to BA. Time-course studies revealed that MBA exhibits significantly longer half-life as observed in the stabilization of HIF and induction of gene targets for up to 72 h compared to BA (24 h). Loss of gene induction was observed in MBA treated cells expressing lentiviral shRNA against HIF1b (HIF1b KD), supporting a HIF-dependent transcription. Furthermore, it’s been widely reported that BA enhances epithelial barrier, primarily through HIF coordinated barrier protection. Among several other BA derivatives, MBA enhanced and prolonged epithelial barrier function in intestinal epithelial cells. In vivo studies in C57BL/6 mice explored the induction of HIF targets in tissue and specifically erythropoietin (EPO) in circulation following administration of BA and MBA at similar doses. These studies revealed that induction of EPO with a single dose of MBA exceeded that of native BA. In colonic and kidney tissue, GLUT1 and BNIP3 were moderately induced in vivo. Thus, a non-endogenous BA derivative (MBA) stabilizes HIF at higher potency and longer half-life than native BA and will be used as a template for the development of HIF stabilizing agents." @default.
• W4362578660 created "2023-04-06" @default.
• W4362578660 creator A5015172358 @default.
• W4362578660 creator A5037786337 @default.
• W4362578660 creator A5049650132 @default.
• W4362578660 creator A5089439811 @default.
• W4362578660 date "2023-04-01" @default.
• W4362578660 modified "2023-09-28" @default.
• W4362578660 title "STRUCTURAL MODIFICATIONS OF BUTYRATE REVEAL TEMPLATES FOR INTESTINAL EPITHELIAL HIF STABILIZERS" @default.
• W4362578660 doi "https://doi.org/10.1053/j.gastro.2023.03.117" @default.
• W4362578660 hasPublicationYear "2023" @default.
• W4362578660 type Work @default.
• W4362578660 citedByCount "0" @default.
• W4362578660 crossrefType "journal-article" @default.
• W4362578660 hasAuthorship W4362578660A5015172358 @default.
• W4362578660 hasAuthorship W4362578660A5037786337 @default.
• W4362578660 hasAuthorship W4362578660A5049650132 @default.
• W4362578660 hasAuthorship W4362578660A5089439811 @default.
• W4362578660 hasConcept C100544194 @default.
• W4362578660 hasConcept C104317684 @default.
• W4362578660 hasConcept C16613235 @default.
• W4362578660 hasConcept C185592680 @default.
• W4362578660 hasConcept C2776979534 @default.
• W4362578660 hasConcept C55493867 @default.
• W4362578660 hasConcept C86339819 @default.
• W4362578660 hasConcept C86803240 @default.
• W4362578660 hasConcept C95444343 @default.
• W4362578660 hasConceptScore W4362578660C100544194 @default.
• W4362578660 hasConceptScore W4362578660C104317684 @default.
• W4362578660 hasConceptScore W4362578660C16613235 @default.
• W4362578660 hasConceptScore W4362578660C185592680 @default.
• W4362578660 hasConceptScore W4362578660C2776979534 @default.
• W4362578660 hasConceptScore W4362578660C55493867 @default.
• W4362578660 hasConceptScore W4362578660C86339819 @default.
• W4362578660 hasConceptScore W4362578660C86803240 @default.
• W4362578660 hasConceptScore W4362578660C95444343 @default.
• W4362578660 hasIssue "4" @default.
• W4362578660 hasLocation W43625786601 @default.
• W4362578660 hasOpenAccess W4362578660 @default.
• W4362578660 hasPrimaryLocation W43625786601 @default.
• W4362578660 hasRelatedWork W1969676666 @default.
• W4362578660 hasRelatedWork W2001677368 @default.
• W4362578660 hasRelatedWork W2009966535 @default.
• W4362578660 hasRelatedWork W2019988726 @default.
• W4362578660 hasRelatedWork W2088063203 @default.
• W4362578660 hasRelatedWork W2097265502 @default.
• W4362578660 hasRelatedWork W2120393042 @default.
• W4362578660 hasRelatedWork W2171277769 @default.
• W4362578660 hasRelatedWork W2776033524 @default.
• W4362578660 hasRelatedWork W4248183732 @default.
• W4362578660 hasVolume "164" @default.
• W4362578660 isParatext "false" @default.
• W4362578660 isRetracted "false" @default.
• W4362578660 workType "article" @default.